Cargando…

Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis

Neurological soft signs (NSS) comprise subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts, which are typically observed in the majority of schizophrenia patients, including chronic cases and neuroleptic-naïve first-episode patients. However, recent studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmann, Silke, Degen, Christina, Geider, Franz Josef, Schröder, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274793/
https://www.ncbi.nlm.nih.gov/pubmed/25566104
http://dx.doi.org/10.3389/fpsyt.2014.00185
_version_ 1782350036309377024
author Bachmann, Silke
Degen, Christina
Geider, Franz Josef
Schröder, Johannes
author_facet Bachmann, Silke
Degen, Christina
Geider, Franz Josef
Schröder, Johannes
author_sort Bachmann, Silke
collection PubMed
description Neurological soft signs (NSS) comprise subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts, which are typically observed in the majority of schizophrenia patients, including chronic cases and neuroleptic-naïve first-episode patients. However, recent studies clearly demonstrate that NSS are not a static feature of schizophrenia but vary in the clinical course of the disorder. This effect was investigated in a meta-analysis based on 17 longitudinal studies published between 1992 and 2012. Studies included between 10 and 93 patients with schizophrenia spectrum disorders (total number 787) with follow-up periods between 2 and 208 weeks. Beside the Neurological Examination Scale, the Cambridge Neurological Inventory and the Heidelberg NSS Scale were used to assess NSS. All but three studies found NSS to decrease in parallel with remission of psychopathological symptoms. This effect was more pronounced in patients with a remitting compared to a non-remitting, chronic course (Cohen’s d 0.81 vs. 0.15) and was significantly correlated with length of the follow-up period (r = −0.64) but not with age (r = 0.28). NSS scores did not decrease to the level typically observed in healthy controls. From a clinical perspective, NSS may therefore be used to identify subjects at risk to develop schizophrenia and to monitor disease progression.
format Online
Article
Text
id pubmed-4274793
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42747932015-01-06 Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis Bachmann, Silke Degen, Christina Geider, Franz Josef Schröder, Johannes Front Psychiatry Psychiatry Neurological soft signs (NSS) comprise subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts, which are typically observed in the majority of schizophrenia patients, including chronic cases and neuroleptic-naïve first-episode patients. However, recent studies clearly demonstrate that NSS are not a static feature of schizophrenia but vary in the clinical course of the disorder. This effect was investigated in a meta-analysis based on 17 longitudinal studies published between 1992 and 2012. Studies included between 10 and 93 patients with schizophrenia spectrum disorders (total number 787) with follow-up periods between 2 and 208 weeks. Beside the Neurological Examination Scale, the Cambridge Neurological Inventory and the Heidelberg NSS Scale were used to assess NSS. All but three studies found NSS to decrease in parallel with remission of psychopathological symptoms. This effect was more pronounced in patients with a remitting compared to a non-remitting, chronic course (Cohen’s d 0.81 vs. 0.15) and was significantly correlated with length of the follow-up period (r = −0.64) but not with age (r = 0.28). NSS scores did not decrease to the level typically observed in healthy controls. From a clinical perspective, NSS may therefore be used to identify subjects at risk to develop schizophrenia and to monitor disease progression. Frontiers Media S.A. 2014-12-23 /pmc/articles/PMC4274793/ /pubmed/25566104 http://dx.doi.org/10.3389/fpsyt.2014.00185 Text en Copyright © 2014 Bachmann, Degen, Geider and Schröder. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Bachmann, Silke
Degen, Christina
Geider, Franz Josef
Schröder, Johannes
Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title_full Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title_fullStr Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title_full_unstemmed Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title_short Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
title_sort neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274793/
https://www.ncbi.nlm.nih.gov/pubmed/25566104
http://dx.doi.org/10.3389/fpsyt.2014.00185
work_keys_str_mv AT bachmannsilke neurologicalsoftsignsintheclinicalcourseofschizophreniaresultsofametaanalysis
AT degenchristina neurologicalsoftsignsintheclinicalcourseofschizophreniaresultsofametaanalysis
AT geiderfranzjosef neurologicalsoftsignsintheclinicalcourseofschizophreniaresultsofametaanalysis
AT schroderjohannes neurologicalsoftsignsintheclinicalcourseofschizophreniaresultsofametaanalysis